Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 6/20 | 0.56 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenolsulfonic Acid SCHEMBL1115421 | 0.97 | LMNA (0.56) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL15023824 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL18577736 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL8781961 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL11084143 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL125056 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL119165 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL8008849 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL11196801 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL1470053 | 0.94 | LMNA (0.59) | LMNACA2CA1CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371844-B | Gypsum-based fireproof paint for steel structure, and preparation method and application thereof | 大厂金隅涂料有限责任公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119818377-A | High-pressure micro-jet long-acting makeup composition and preparation method and application thereof | 广州品赫化妆品有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119627257-A | Additive, electrolyte and battery | 香港理工大学 | 2025-03-14 | — | — | CN | claimed |
| CN-119371844-A | Gypsum-based fireproof paint for steel structure, and preparation method and application thereof | 大厂金隅涂料有限责任公司 | 2025-01-28 | — | — | CN | claimed |
| CN-116254060-B | Grinding aid, preparation method, application and grinding fluid containing grinding aid | 大连奥首科技有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-118899387-A | Double-doped positive electrode active material, aqueous solution sodium ion battery and electronic device | 北京智慧能源研究院 | 2024-11-05 | — | — | CN | claimed |
| CN-117940109-A | Composition for preventing bromhidrosis | 持田制药株式会社 | 2024-04-26 | — | — | CN | claimed |
| CN-117915984-A | Skin treatment device, method for operating skin treatment device, skin treatment method, and program | 雅萌股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| EP-3677251-B1 | WATER-IN-OIL EMULSION-TYPE STICK-LIKE DEODORANT AGENT | SHINETSU CHEMICAL CO (JP) | 2023-08-16 | — | — | EP | claimed |
| CN-116093244-A | Zinc metal negative electrode with in-situ multifunctional organic-inorganic interface layer and preparation method and application thereof | 中南大学 | 2023-05-09 | — | — | CN | claimed |
| EP-1602685-B1 | Pressing granulated fire retardant composition | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2011-02-02 | — | — | EP | claimed |
| US-7452661-B2 | Photothermographic materials incorporating antifoggants | CARESTREAM HEALTH, INC. (US) | 2008-11-18 | — | — | US | claimed |
| US-20080206688-A1 | PHOTOTHERMOGRAPHIC MATERIALS INCORPORATING ANTIFOGGANTS | QUANTUM MEDICAL IMAGING, L.L.C. | 2008-08-28 | — | — | US | claimed |
| US-20080014288-A1 | Zinc-containing treatments for hyperphosphatemia | GENZYME CORPORATION | 2008-01-17 | — | — | US | claimed |
| US-20050272839-A1 | Compression-granulated flame retardant composition | CLARIANT GMBH | 2005-12-08 | — | — | US | claimed |
| EP-1602685-A1 | Pressing granulated fire retardant composition | Clariant GmbH (DE) | 2005-12-07 | — | — | EP | claimed |
| US-20040223932-A1 | Adhesive treatment for acne | CLOSURE MEDICAL CORPORATION | 2004-11-11 | — | — | US | claimed |
| EP-1145707-A1 | COMPOSITIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2001-10-17 | — | — | EP | claimed |
| EP-0506670-B1 | MICROWAVE SUSCEPTOR WITH ATTENUATOR FOR HEAT CONTROL | GOLDEN VALLEY MICROWAVE FOODS (US) | 1996-11-20 | — | — | EP | claimed |
| US-4478926-A | STABILIZERS | ANDREWS PAPER & CHEMICAL CO., INC. (US) | 1984-10-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223932-A1 | Adhesive treatment for acne | CUTA, KRT18, COL14A1 | LMNA 2583/4885CA2 4745/4885CA1 4709/4885 |
| US-20080014288-A1 | Zinc-containing treatments for hyperphosphatemia | SLC30A5, SLC30A6, SLC39A3 | LMNA 4469/4885CA2 62/4885CA1 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.